antibody

Documents about antibody

• Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation#885502ClinicalTrials.gov
• Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma#872696ClinicalTrials.gov
• Case Report: Two atypical cases of M6-like antimitochondrial antibody pattern unlinked to iproniazid#246743HAL (France)
• The Birth of Influenza Immunity: High-Resolution Antibody Dynamics Driven by Maternal Antibody Waning, Vaccinations, and Infections during the first Two Years of Life#259238bioRxiv / medRxiv
• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics#651923Europe PMC
• A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors#838646ClinicalTrials.gov
• PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients#883252ClinicalTrials.gov
• Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer#233740UNC Dataverse Dataverse OAI Archive
• Glycosylation penetrance of N-X-S/T sequons in antibody variable domains: a structural survey of 19,265 human antibody structures reassessing the histidine/glutamine suppression hypothesis.#395967NCBI PubMed Central
• Early Oxygen Requirement in Patients with Mild-to-Moderate COVID-19 Who Received Regdanvimab after Delta- Variant Outbreak#450663S-Space: Seoul National University
• Anti-PD-1 Antibody Plus Chidamide and Rituximab Regimen in Relapsed or Refractory DLBCL (PCR)#862429ClinicalTrials.gov
• Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma#892650ClinicalTrials.gov
• Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production#4729Europe PMC
• Subcutaneous drug delivery of high concentration antibody products - part 2: formulation, device options, and clinical bridging strategies for patient-centric commercial presentations#273470Europe PMC
• Monoclonal antibody potentiating gonadotropin activity in vitro and in vivo in male and female rats and in ewes#304527HAL (France)
• Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants#330087HAL (France)
• Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma#803524ClinicalTrials.gov
• Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients#805517ClinicalTrials.gov
• Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors#874942ClinicalTrials.gov
• PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma#889476ClinicalTrials.gov
• Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome#234565ClinicalTrials.gov
• Trends in HIV antibody testing#488699SJSU ScholarWorks
• Investigation of the Interaction and Olgiomerization of Hiv Capsid and Single Domain Antibody as a Biotechnological Drug Against Hiv#195251İzmir Yüksek Teknoloji Enstitüsü
• Antibody-Dependent Immune Complex Signaling and Inflammatory Cytokine Responses in Acute Febrile Illness: A Mechanistic Study in Arboviral and Leptospiral Infection#253648Europe PMC
• Clostridioides difficile Immunity During Pregnancy and Passive Antibody Transfer to Neonates from Cord Blood and Breast Milk#374410HAL (France)
• Computational study of the antibody-antigen properties to develop binders for viral proteins#395275HAL (France)
• Experimental and Computational Insight into the pH-Dependent Binding of Poly(glutamate)–Monoclonal Antibody Complexes for Biopharmaceutical Formulation#411828HAL (France)
• Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy#807181ClinicalTrials.gov
• Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101#877145ClinicalTrials.gov
• A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma#886501ClinicalTrials.gov
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation#6968OpenAlex
• Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties.#452337Lund University Publications
• Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19#826938ClinicalTrials.gov
• Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer#869607ClinicalTrials.gov
• Duration of IPV Priming and Antibody Decay#332806ClinicalTrials.gov
• Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders.#409222NCBI PubMed Central
• COVID-19 Antibody Responses In Cystic Fibrosis#836102ClinicalTrials.gov
• Study Evaluating Bapineuzumab In Alzheimer Disease Subjects#878821ClinicalTrials.gov
• TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer#467565ClinicalTrials.gov
• COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies#838735ClinicalTrials.gov
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease#867560ClinicalTrials.gov
• Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses#274245HAL (France)
• An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs#403252OpenAlex
• Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults#886337ClinicalTrials.gov
• Trial of Antibody Responses by Vitamin Supplementation#141087ClinicalTrials.gov
• Antibody therapies in glioblastoma: Overcoming micro-environmental barriers.#151454NCBI PubMed Central
• Trial watch: antibody-drug conjugates in cancer therapy.#165698NCBI PubMed Central
• Mechanisms of Antibody-Mediated Immunity Against Class 1 Viral Fusion Glycoproteins#256651EliScholar
• Antibody-Antigen Affinity Prediction with Chain-Aware Protein Language Modeling#383435bioRxiv / medRxiv
• Nanoparticle-Target Interactions Parallel Antibody-Protein Interactions#643642Harvard DASH